Positive outcomes for hepatitis C transplant patients

There is new hope for the notoriously difficult-to-treat population of liver transplant patients with recurring hepatitis C, researchers have announced. Hepatitis C infection is a common cause of liver transplantation, with virus-related diseases comprising 40% of primary indications for liver transplantation in Europe among patients with cirrhosis. More than 5,500 liver transplantations are currently performed in Europe per year.

Read the whole article on Science Daily

More from Science Daily